STAAR OVARIAN CANCER (EIN 844672869) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

NICOLE ANDREWS

Phone

2819239051

Tax Period

2023-01-01 to 2023-12-31

STAAR OVARIAN CANCER, founded in 2020, is a small nonprofit in the Medical Research sector that reported $311K in total revenue in fiscal year 2022. Expenses of $514K exceeded revenue, resulting in a 65% operating deficit.

Mission

STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPLE OF OVARIAN CANCER IN THE UNITED STATES. WE DRIVE AWARENESS OF THE SYMPTOBS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE STRENGTHEN OUR CONNECTIONS WITH RESEARCHERS TO UNDERSTAND RESEARCH NEEDS, FUNDING NEEDS, AND HISTORICALLY RAISED ENOUGH FUNDS THROUGH DONATIONS TO GIVE THREE RESEARCH GRANTS FOR LGSOC. ONE OF THE FUNDED STUDIES WAS FUNDED WITH MONEY DONATED IN 2021.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $327,751

Program Service Revenue $71,500

Investment Income $337

Other Revenue $0

TOTAL REVENUE $399,588

Expense Breakdown

Grants Paid $153,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $277,067

Other Expenses $124,067

TOTAL EXPENSES $277,067

Year-over-Year Comparison

	2023	2022	Change
Revenue	$399,588	$310,800	+0.3%
Expenses	$277,067	$513,766	-0.5%
Net Income	$122,521	$-202,966	-1.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELLIE HABIB	DIRECTOR	2.00	Director	$0	$0	$0
MADALYN KENNEY	DIRECTOR	1.00	Director	$0	$0	$0
BAILEY WOLFE	DIRECTOR	1.00	Director	$0	$0	$0
NICOLE ANDREWS	CHAIR	10.00	Officer	$0	$0	$0
CHRISTINA CAMPBELL	TREASURER	2.00	Officer	$0	$0	$0
MORGAN GAYNOR	SECRETARY	2.00	Officer	$0	$0	$0
KARI NEUMEYER	V-CHAIR MARK	2.00	Officer	$0	$0	$0
EMMA SCHLAMM	DIRECTOR	2.00	Officer	$0	$0	$0
ALYSSA TOOMES	V-CHAIR FUND	2.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$399,588	$277,067	$448,000	$122,521
2022	$310,800	$513,766	$164,305	$-202,966

STAAR OVARIAN CANCER